Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)

Clinical trial NCT04575597 · COMPLETED

Trial details

NCT number: NCT04575597
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Coronavirus Disease (COVID-19)

Start date: 2020-10-19
Primary completion: 2022-05-05
Enrollment: 1735

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.